Forum Klix.ba

pozdrav dali moze neko da mi pomogne treba mi hitno inekcija sandostatin lar 30 mg u bosni nema mogucnosti da se nabavi treba mi za smanjenje povecanog lucenja hormona rasta akromegalija sa tumorom na hipofizi ,ako bi netko mogao da mi kaze gdje se moze nabaviti i po kojoj cijeni jer sam cuo da je jako skup svaka informacija je dobro dosla ili ako neko poklanja jer nisam u mogucnosti platiti oko 5000 km za tu inekciju ,hvala svima na odgovoru

nažalost nemam nikakav info.


tema na vrh!

Sandostatin ti ima Hercegovinalijek u Rajlovcu, samo je problem u tome što je 10000KM lijek.

Ali evo kontakt, pa provjeri opet:
https://www.hercegovinalijek.ba/kontakti

Mega Man X wrote:Sandostatin ti ima Hercegovinalijek u Rajlovcu, samo je problem u tome što je 10000KM lijek.

I koliko ta količina za 10.000KM traje?

Ajatolah_ wrote:

Mega Man X wrote:Sandostatin ti ima Hercegovinalijek u Rajlovcu, samo je problem u tome što je 10000KM lijek.

I koliko ta količina za 10.000KM traje?

Ne znam koliko si ljudino dobar sa Engleskim ali evo što sam našao o tome:

"It is recommended to start treatment with the administration of 20 mg Sandostatin LAR at 4-week intervals for 3 months. Patients on treatment with s.c. Sandostatin can start treatment with Sandostatin LAR the day after the last dose of s.c. Sandostatin. Subsequent dosage adjustment should be based on serum growth hormone (GH) and insulin-like growth factor 1/somatomedin C (IGF-1) concentrations and clinical symptoms.

For patients in whom, within this 3-month period, clinical symptoms and biochemical parameters (GH; IGF-1) are not fully controlled (GH concentrations still above 2.5 microgram/L), the dose may be increased to 30 mg every 4 weeks. If after 3 months, GH, IGF-1, and/or symptoms are not adequately controlled at a dose of 30 mg, the dose may be increased to 40 mg every 4 weeks.

For patients whose GH concentrations are consistently below 1 microgram/L, whose IGF-1 serum concentrations normalised, and in whom most reversible signs/symptoms of acromegaly have disappeared after 3 months of treatment with 20 mg, 10 mg Sandostatin LAR may be administered every 4 weeks. However, particularly in this group of patients, it is recommended to closely monitor adequate control of serum GH and IGF-1 concentrations, and clinical signs/symptoms at this low dose of Sandostatin LAR.

For patients on a stable dose of Sandostatin LAR, assessment of GH and IGF-1 should be made every 6 months."


Više o Sandostatin LAR-u ovdje: https://www.medicines.org.uk/emc/medicine/1321